Skip to Main Content

Author Details

Frank C Kuo
1988
93
44
PMIDPaper TitleJournal TitlePublished Year
34638128A germinal center-associated microenvironmental signature reflects malignant phenotype and outcome of DLBCL.Blood advances2022
31837959Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial.Lancet Haematol2020
31855703Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.Lung Cancer2020
32188490Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma.Genome Medicine2020
31305863Premalignant Clonal Hematopoietic Proliferations.American Journal of Clinical Pathology2019
30573040Next generation sequencing in hematolymphoid neoplasia.Seminars in Hematology2019
30767667The Distribution Volume of <sup>18</sup>F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy.Cancer Biother Radiopharm2019
31141600Introduction.American Journal of Clinical Pathology2019
30842135Granular cell tumour in male breast mimicking breast carcinoma.BMJ Case Reports2019
31310240Avoiding peripheral nerve injury in arterial interventions.Diagnostic and Interventional Radiology2019
31309983Germline Predisposition to Hematolymphoid Neoplasia.American Journal of Clinical Pathology2019
29724895High <i>NPM1</i>-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.Blood2018
29467336Frameshift events predict anti-PD-1/L1 response in head and neck cancer.JCI Insight2018
29326119Association of mutations with morphological dysplasia in acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities.Haematologica2018
29274134A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcome.American Journal of Hematology2018
27863258Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing.J Mol Diagn2017
28557599Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.2017
28600338The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice.Blood2017
28384399Molecular Analysis of Genetic Markers for Non-Hodgkin Lymphomas.Current Protocols in Human Genetics2017
28370403NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO classification.American Journal of Hematology2017
28446434Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias.Blood2017
28407280Coil-assisted retrograde transvenous obliteration and partial splenic artery embolization for hepatic encephalopathy.Hepatology2017
28472420Determination of VH Family Usage in B-Cell Malignancies via the BIOMED-2 IGH PCR Clonality Assay.American Journal of Clinical Pathology2017
29296824Systematic <i>STAT3</i> sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia.Blood Adv2017
27241017Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant.Leukemia and Lymphoma2017
28075487Molecular Analysis of Gene Rearrangements and Mutations in Acute Leukemias and Myeloid Neoplasms.Current Protocols in Human Genetics2017
28297627Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.Journal of Clinical Oncology2017
28054397Conventional cytogenetics for myeloid neoplasms in the era of next-generation-sequencing.Am J Hematol2017
27959687Case 37-2016. An 86-Year-Old Woman with Leukocytosis and Splenomegaly.N Engl J Med2016
27339098Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies.Journal of Molecular Diagnostics2016
26913631Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva.JAMA Oncology2016
26829311KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.J Thorac Oncol2016
27523973Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.Surgical Pathology Clinics2016
27882345Institutional implementation of clinical tumor profiling on an unselected cancer population.JCI Insight2016
25231023Targeted genomic analysis of Müllerian adenosarcoma.Journal of Pathology2015
25933675Next-generation sequencing-based panel testing for myeloid neoplasms.Current Hematologic Malignancy Reports2015
27148573Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.Cold Spring Harb Mol Case Stud2015
27148563Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay.Cold Spring Harb Mol Case Stud2015
26175414Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.Cancer Cell2015
26407235A Phase 1 study of the novel gamma-secretase inhibitor PF-03084014 in patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.Blood Cancer J2015
24843823Pathology informatics fellowship training: Focus on molecular pathology.J Pathol Inform2014
25441687Ewing sarcoma mimicking atypical carcinoid tumor: detection of unexpected genomic alterations demonstrates the use of next generation sequencing as a diagnostic tool.Cancer genetics2014
25426837Age-related clonal hematopoiesis associated with adverse outcomes.N Engl J Med2014
24909865Simultaneous ECG-gated PET imaging of multiple mice.Nucl Med Biol2014
25191621The ongoing evolution of the core curriculum of a clinical fellowship in pathology informatics.J Pathol Inform2014
24984190Immuno-PET imaging of tumor endothelial marker 8 (TEM8).Mol Pharm2014
25171694Computational pathology: an emerging definition.Arch Pathol Lab Med2014
25157968Prospective enterprise-level molecular genotyping of a cohort of cancer patients.J Mol Diagn2014
24238397Effects of and satisfaction with short message service reminders for patient medication adherence: a randomized controlled study.BMC Med Inform Decis Mak2013
23024889Different tracks for pathology informatics fellowship training: Experiences of and input from trainees in a large multisite fellowship program.J Pathol Inform2012
  • 1 - 50 of 93

Recommended Authors

Collaborators

Dana-Farber Cancer Institute
Co-authored papers 8
Co-authored papers 8
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Novartis Institutes for BioMedical Research
Co-authored papers 5
Co-authored papers 5
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Co-authored papers 4
Geisinger Commonwealth School of Medicine
Co-authored papers 4
Co-authored papers 4
Dana Farber Cancer Institute
Co-authored papers 4
Broad Institute
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Massachusetts General Hospital
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Broad Institute of Harvard and MIT
Co-authored papers 3
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Co-authored papers 3
University of Pittsburgh School of Medicine
Co-authored papers 2
Co-authored papers 2
Dana-Farber Cancer Institute, Harvard Medical School, Brigham and Women's Hospital
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Merck & Co.
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 2
Co-authored papers 2